🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary hypothesis is that cancer vaccine can convert non-immunogenic g...
Status
Unknown
Location
National University Hospital
Start Date
2019-02-21
Trial ID
NCT03784040
Treatments Being Tested
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
A one-arm, single center phase 2 trial of SAbR plus ipilimumab plus nivolum...
Status
Withdrawn
Location
University of Texas Southwestern Medical Center - Dallas
Start Date
2018-03-01
Trial ID
NCT03126461
Treatments Being Tested
Patients suffering from diffuse large B-cell lymphoma (DLBCL) who relapse w...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2018-05-15
Trial ID
NCT03311958
Treatments Being Tested
This is an open-label, non-randomized, multicenter, Phase 1/2a study to eva...
Status
Terminated
Location
Rambam Medical Center
Start Date
2022-11-15
Trial ID
NCT05581719
Treatments Being Tested
Background: Gastrointestinal cancer is one of the most common cancers worl...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2020-08-09
Trial ID
NCT04166383
Treatments Being Tested
This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Status
Terminated
Location
City of Hope
Start Date
2018-06-26
Trial ID
NCT03547999
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and eff...
Status
Completed
Location
The University of Alabama Birmingham (UAB)
Start Date
2017-10-09
Trial ID
NCT03241173
Treatments Being Tested
Investigators hypothesize that following first-line platinum based chemothe...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2019-03-28
Trial ID
NCT03639935
Primary Objectives: 1. To determine the maximum tolerated dose (MTD) or ma...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2017-03-27
Trial ID
NCT03059147